You have 9 free searches left this month | to do more
Showing 1 - 25 of
66 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
O
An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED) - 2005
Completed
  • Psychosis
  • Asenapine WHITE raspberry flavor (Treatment A)
  • +2 more
  • (no location specified)
2022-02-02
Feb 2, 2022
O
Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) - 2015
Completed
Has Results
  • Schizophrenia
  • Asenapine
  • Placebo
  • (no location specified)
2022-02-03
Feb 3, 2022
O
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) - 2014
Completed
Has Results
  • Schizophrenia
  • Asenapine
  • +3 more
  • (no location specified)
2022-02-07
Feb 7, 2022
O
To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) - 2008
Completed
Has Results
  • Schizophrenia
  • Asenapine - Open Label
  • +2 more
  • (no location specified)
2022-02-04
Feb 4, 2022
O
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107) - 2013
Completed
Has Results
  • Bipolar Disorder, Pediatric
  • asenapine
  • +2 more
  • (no location specified)
2022-02-03
Feb 3, 2022
O
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) - 2013
Completed
Has Results
  • Schizophrenia, Paranoid
  • +2 more
  • asenapine 2.5 mg
  • +2 more
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) - 2008
Completed
Has Results
  • Psychosis
  • Asenapine
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) - 2006
Completed
  • Schizophrenia
  • Asenapine
  • +2 more
  • (no location specified)
2022-02-04
Feb 4, 2022
O
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) - 2011
Completed
Has Results
  • Schizophrenia
  • Bipolar I Disorder
  • Asenapine 2.5 mg
  • +2 more
  • (no location specified)
2022-02-02
Feb 2, 2022
O
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) - 2014
Completed
Has Results
  • Schizophrenia
  • Asenapine 5 mg
  • +2 more
  • (no location specified)
2022-02-03
Feb 3, 2022
O
Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) - 2007
Completed
Has Results
  • Schizophrenia
  • (no location specified)
2022-02-04
Feb 4, 2022
O
Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691) - 2014
Completed
Has Results
  • Bipolar 1 Disorder
  • Asenapine
  • Placebo
  • (no location specified)
2022-02-07
Feb 7, 2022
O
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) - 2008
Completed
Has Results
  • Schizophrenia
  • (no location specified)
2022-02-07
Feb 7, 2022
O
40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) - 2007
Completed
Has Results
  • Bipolar Disorder
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) - 2014
Completed
Has Results
  • Schizophrenia
  • Asenapine
  • (no location specified)
2022-02-02
Feb 2, 2022
O
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) - 2009
Completed
Has Results
  • Schizophrenia
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) - 2014
Completed
Has Results
  • Bipolar Disorder
  • Asenapine
  • Rescue medication
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) - 2013
Completed
Has Results
  • Schizophrenia, Paranoid
  • +2 more
  • asenapine
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) - 2006
Completed
  • Schizophrenia
  • asenapine
  • +2 more
  • (no location specified)
2022-02-04
Feb 4, 2022
O
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) - 2006
Completed
  • Schizophrenia
  • asenapine
  • +2 more
  • (no location specified)
2022-02-03
Feb 3, 2022
O
9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) - 2006
Completed
  • Bipolar Disorder
  • (no location specified)
2022-02-02
Feb 2, 2022
O
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) - 2006
Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) - 2007
Completed
  • Schizophrenia
  • (no location specified)
2022-02-04
Feb 4, 2022
O
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) - 2007
Completed
  • Schizophrenia
  • (no location specified)
2022-02-07
Feb 7, 2022
O
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) - 2008
Completed
Has Results
  • Schizophrenia
  • (no location specified)
2022-02-04
Feb 4, 2022